![The Blood Triglyceride:HDL Ratio and LDL Particle Size: Critical Issues for Determining Risk of Coronary Heart Disease! | The Cooper Institute The Blood Triglyceride:HDL Ratio and LDL Particle Size: Critical Issues for Determining Risk of Coronary Heart Disease! | The Cooper Institute](https://uploads-ssl.webflow.com/62cc5493bad4821d71779067/63975ba375e66ccc6e574556_LDL-CHD%255B1%255D.png)
The Blood Triglyceride:HDL Ratio and LDL Particle Size: Critical Issues for Determining Risk of Coronary Heart Disease! | The Cooper Institute
![Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina | Scientific Reports Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-00020-3/MediaObjects/41598_2021_20_Fig1_HTML.png)
Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina | Scientific Reports
![Personalizing cholesterol treatment recommendations for primary cardiovascular disease prevention | Scientific Reports Personalizing cholesterol treatment recommendations for primary cardiovascular disease prevention | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-03796-6/MediaObjects/41598_2021_3796_Fig1_HTML.png)
Personalizing cholesterol treatment recommendations for primary cardiovascular disease prevention | Scientific Reports
![JCM | Free Full-Text | Statin Treatment in Specific Patient Groups: Role for Improved Cardiovascular Risk Markers JCM | Free Full-Text | Statin Treatment in Specific Patient Groups: Role for Improved Cardiovascular Risk Markers](https://pub.mdpi-res.com/jcm/jcm-09-03748/article_deploy/html/images/jcm-09-03748-ag.png?1606353158)
JCM | Free Full-Text | Statin Treatment in Specific Patient Groups: Role for Improved Cardiovascular Risk Markers
![Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium - The Lancet Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium - The Lancet](https://www.thelancet.com/cms/attachment/0c37580c-c143-4f36-88f9-6b0d46ba0da9/gr1_lrg.jpg)